Bad Animal Data is Big News!


News headlines 20th June to 23rd July 2010

‘Curis Tumbles on Failure of Cancer Drug Trial: Biotech's Latest Mishaps.’
Bullfax. 20 June 2010.

‘Pfizer pulls leukemia drug from U.S. market.
Drugmaker Pfizer Inc is pulling a decade-old leukemia medicine off the U.S. market after a study found a higher death rate and no benefit for patients.’

Reuters. 21 June 2010.

'Mylotarg (gemtuzumab ozogamicin): Market Withdrawal.'
FDA Medwatch. 21 June 2010.

‘Pfizer Suspends Trial of Tanezumab for Osteoarthritis Pain at U.S. Request’
Bloomberg. 23 June 2010.

‘Glaxo Settles Nearly 200 Paxil Birth Defect Lawsuits.’
Pharmalot. 23 June 2010.

'Pfizer shares fall over problems with pain drug.'
Bloomberg Business Week. 24 June 2010

'EU regulators probe risks of blood pressure drugs.'
Reuters. 25 June 2010

'Study raises questions over wider use of statins.'
Reuters. 28 June 2010 

'Lilly’s Effient Tied to More Cancer Risk Than Plavix.'
Bloomberg Business Week. 28 June 2010

‘Merck to fight $8M Fosamax verdict.
Merck has lost its first Fosamax jury trial.  A New York jury awarded $8 million in damages to plaintiff Shirley Boles, who claimed her osteonecrosis of the jaw was caused by the bone-building drug.’

Fiercepharma. 28 June 2010

'US FDA probes possible risks of Lilly drug, others.  Lilly's Effient, Sanofi's Multaq under review.' 
Reuters. 30 June 2010

'Rosiglitazone is linked to heart failure, stroke, and death.'
BMJ.  1 July 2010, JAMA 2010; doi:10.1001/jama.2010.920. Arch Intern Med 2010;

‘Testosterone Gel Trial Ends After Heart Issue’
New York Times. 5 July 2010.

‘Second big setback for XenoPort: Migraine drug fails test.’
Mercury News. 7 July 2010.

‘Warning on Liver Injury with Propylthiouracil.’
FDA. July 2010.

‘Glaxo, Xenoport migraine drug fails, shares fall.’
Reuters. 7 July 2010.

‘Arava (leflunomide): Boxed Warning - Risk of Severe Liver Injury.’
FDA. 13 July 2010.

‘Glaxo pays $460 million to resolve Avandia suits. It was facing more than 13,000 claims alleging that it hid the diabetes drug's heart-attack risk.’
Philadelphia Inquirer. 14 July 2010.  

‘Glaxosmithkline to settle claims. GlaxoSmithKline will post a record £1.57billion legal charge during the ­second quarter
GlaxoSmithKline will post a record £1.57billion legal charge during the ­second quarter to settle a host of claims relating to blockbuster diabetes pill Avandia and depression treatment Paxil.’

Daily Express. 16 July 2010.

‘FDA panel rejects diet drug.’s
Post-Gazette. 16 July 2010. 

‘Promising Breast Cancer Drug Fails FDA Test. New Study Shows Little Result Compared To Chemotherapy Alone.’ FoxReno. 19 July 2010‘Pfizer forced to halt pain drug trials.’
Inpharm. 20 July 2010

‘Glaxo says settles some Paxil birth-defect cases.’
Reuters. 20 July 2010

‘Trials of 'unsafe' drug for diabetes stopped.’
Times of India. 23 July 2010.

See the new VIN website:
Information for abolition


Related Articles:

From Dusk 'til Dawn
An Insider's View of the Growth of the Animal Liberation Movement

© Keith Mann